Skip to main navigation Skip to search Skip to main content

Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial

  • Anthony Rodgers*
  • , Abdul Salam
  • , Aletta E. Schutte
  • , William C. Cushman
  • , H. Asita de Silva
  • , Gian Luca Di Tanna
  • , Diederick E. Grobbee
  • , Krzysztof Narkiewicz
  • , Dike B. Ojji
  • , Neil R. Poulter
  • , Markus P. Schlaich
  • , Suzanne Oparil
  • , Wilko Spiering
  • , Bryan Williams
  • , Jackson T. Wright
  • , P. Lakshman
  • , W. Uluwattage
  • , P. Hay
  • , T. Pereira
  • , N. Amarasena
    • G. Ranasinghe, Chris Gianacas, Mathangi Shanthakumar, Xiaoqiu Liu, Nelson Wang, Sonali R. Gnanenthiran, Paul K. Whelton,
*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial'. Together they form a unique fingerprint.
Sort by

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science